Evidence map›Paper›PMID 40342826›Full record

ArticleFrontiers in oncology2025

Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early.

Mariangela Morelli, Francesca Lessi, Serena Barachini, Romano Liotti, Nicola Montemurro, Paolo Perrini, Orazio Santo Santonocito, Carlo Gambacciani, Matija Snuderl, Francesco Pieri and 16 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors.

Mariangela MorelliSection of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
Francesca LessiSection of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
Serena BarachiniSection of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
Romano LiottiSection of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
Nicola MontemurroDepartment of Neurosurgery, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Paolo PerriniDepartment of Neurosurgery, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Orazio Santo SantonocitoNeurosurgical Department of Spedali Riuniti di Livorno, Livorno, Italy.
Carlo GambaccianiNeurosurgical Department of Spedali Riuniti di Livorno, Livorno, Italy.
Matija SnuderlDepartment of Pathology, New York University (NYU) Langone Medical Center, New York City, NY, United States.
Francesco PieriNeurosurgical Department of Spedali Riuniti di Livorno, Livorno, Italy.
Filippo AquilaNeurosurgical Department of Spedali Riuniti di Livorno, Livorno, Italy.
Azzurra FarnesiNeurosurgical Department of Spedali Riuniti di Livorno, Livorno, Italy.
Antonio Giuseppe NaccaratoDepartment of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Paolo ViacavaAnatomical Pathology Department, Azienda Ospedaliera Toscana Nord-ovest, Livorno, Italy.
Francesco CardarelliNational Enterprise for nanoScience and nanoTechnology (NEST), Scuola Normale Superiore and Istituto Nanoscienze-CNR, Pisa, Italy.
Gianmarco FerriNational Enterprise for nanoScience and nanoTechnology (NEST), Scuola Normale Superiore and Istituto Nanoscienze-CNR, Pisa, Italy.
Paul MulhollandDepartment of Oncology, University College London Hospitals, London, United Kingdom.
Diego OttavianiDepartment of Oncology, University College London Hospitals, London, United Kingdom.
Fabiola PaiarDepartment of Radiation Oncology, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
Gaetano LibertiDepartment of Neurosurgery, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
Francesco PasqualettiDepartment of Radiation Oncology, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa, Italy.
Michele MenicagliSection of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
Paolo AretiniSection of Bioinformatics, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
Giovanni SignoreSection of Nanomedicine, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
Sara FranceschiSection of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.
Chiara Maria MazzantiSection of Genomics and Transcriptomics, Fondazione Pisana per la Scienza, San Giuliano Terme, Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.969812.].

Indexed as

drug response assayFLIM (fluorescence lifetime imaging microscopy)glioblastomametabolic imagingpredictive model

Identifiers

PMID40342826
PMCPMC12059221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.